Catalyst

Slingshot members are tracking this event:

Phase 3 data of hGH-CTP in adults with growth hormone deficiency likely due 2H 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
OPK Community voting in process

Additional Information

Additional Relevant Details The study is expected to end toward the second half of 2016; regulatory submission will follow study completion.
http://investor.opko...
Additional Relevant Details Update on Jun 15 2017: OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults
http://investor.opko...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 30, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Data, Hgh-ctp, Growth Hormone Deficiency, 2h 2016